陳家亮 教授

研究範疇 <只提供英文版本>

1. Management of anti-thrombotics in gastrointestinal bleeding
2. Non-invasive colorectal cancer diagnosis
3. Clinical applications of gut microbiota”

履歷概要 <只提供英文版本>

Professor Chan Ka Leung, Francis, is a world-renowned clinician scientist in Gastroenterology and an entrepreneur.  An author of over 860 full scientific articles in high impact international journals with h-index of 105 and the named inventor of over 125 patents, Professor Chan is the first in academic history who has published 8 first-author original research articles in two prestigious medical journals, namely The New England Journal of Medicine and The Lancet.

Professor Chan’s research on the prevention of NSAID- and aspirin-related GI bleeding has led to major revisions to clinical practice guidelines in the US, Europe and the Asia-Pacific region, which does not only benefit numerous patients around the globe but also contributes to the medical field in different countries.

In recent years, he has focused on the translational research of gut microbiota and co-founded a microbiota start-up company, GenieBiome Limited, in 2019 with the aim of bringing health and hope to our next generation through transforming groundbreaking research into clinical applications and helping transform Hong Kong into an international innovation and technology hub in Asia.